miR-150 increases the sensitivity of natural killer/ T (NK/T) cell lymphoma to ionizing radiation through suppression of phosphoinositide 3-kinases/ serine-threonine protein kinas/ mechanistic target of rapamycin kinase (PI3K/AKT/mTOR) pathway [12] and in MM it has seen that less expression of miR-155 related to resistance to bortezomib [13]. The gene discussed is MTOR; the disease is T-cell non-Hodgkin lymphoma.